Atlas Trials

A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK

Clinical trial NCT05357820 · COMPLETED

Trial details

NCT number
NCT05357820
Sponsor
Nuvation Bio Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2021-07-19
Primary completion
2021-12-03
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.